{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:31:14Z","timestamp":1793741474203,"version":"4.6.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,15]],"date-time":"2027-02-15T00:00:00Z","timestamp":1802649600000},"content-version":"am","delay-in-days":624,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973662"],"award-info":[{"award-number":["81973662"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404547"],"award-info":[{"award-number":["82404547"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304731"],"award-info":[{"award-number":["82304731"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017520","name":"Chengdu Medical College","doi-asserted-by":"publisher","award":["2024yxGzn04"],"award-info":[{"award-number":["2024yxGzn04"]}],"id":[{"id":"10.13039\/100017520","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Colloid and Interface Science"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jcis.2025.02.045","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T16:48:01Z","timestamp":1739292481000},"page":"248-260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Co-delivery of doxorubicin and glycyrrhetinic acid via acid\/glutathione dual responsive nano-prodrug with sodium bicarbonate carry-on for advanced combinational cancer treatment"],"prefix":"10.1016","volume":"687","author":[{"given":"Chuan","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziye","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcis.2025.02.045_b0005","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.radonc.2020.06.041","article-title":"Augmenting the therapeutic window of radiotherapy: A perspective on molecularly targeted therapies and nanomaterials","volume":"150","author":"Reda","year":"2020","journal-title":"Radiother. Oncol."},{"issue":"18","key":"10.1016\/j.jcis.2025.02.045_b0010","first-page":"316","article-title":"The screening, diagnosis, treatment, and follow-up of breast cancer","volume":"115","author":"W\u00f6ckel","year":"2018","journal-title":"Dtsch. Arztebl. Int."},{"key":"10.1016\/j.jcis.2025.02.045_b0015","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ctrv.2017.04.008","article-title":"Mechanisms of resistance to systemic therapy in metastatic castration-resistant prostate cancer","volume":"57","author":"Galletti","year":"2017","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.jcis.2025.02.045_b0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijpharm.2018.12.022","article-title":"Dissolvable microneedle patch containing doxorubicin and docetaxel is effective in 4T1 xenografted breast cancer mouse model","volume":"556","author":"Bhatnagar","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"13","key":"10.1016\/j.jcis.2025.02.045_b0025","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.addr.2009.05.006","article-title":"Combination therapy: Opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines","volume":"61","author":"Greco","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jcis.2025.02.045_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.558741","article-title":"Celastrol: A review of useful strategies overcoming its limitation in anticancer application","volume":"11","author":"Shi","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jcis.2025.02.045_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153408","article-title":"Synergistic breast cancer suppression efficacy of doxorubicin by combination with glycyrrhetinic acid as an angiogenesis inhibitor","volume":"81","author":"Shi","year":"2021","journal-title":"Phytomedicine"},{"issue":"14","key":"10.1016\/j.jcis.2025.02.045_b0040","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.3390\/molecules27144478","article-title":"Doxorubicin-based hybrid compounds as potential anticancer agents: A review","volume":"27","author":"Peter","year":"2022","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.jcis.2025.02.045_b0045","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.apsb.2023.12.008","article-title":"Nano-formulated delivery of active ingredients from traditional Chinese herbal medicines for cancer immunotherapy","volume":"14","author":"Shang","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jcis.2025.02.045_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1223933","article-title":"Acrocomia aculeata associated with doxorubicin: cardioprotection and anticancer activity","volume":"14","author":"Monteiro-Alfredo","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.jcis.2025.02.045_b0055","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1517\/14728222.2015.1012156","article-title":"Glycyrrhetinic acid potently suppresses breast cancer invasion and metastasis by impairing the p38 MAPK-AP1 signaling axis","volume":"19","author":"Wang","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"issue":"5","key":"10.1016\/j.jcis.2025.02.045_b0060","doi-asserted-by":"crossref","first-page":"498","DOI":"10.2174\/0929867323666160112122256","article-title":"Glycyrrhetinic acid and its derivatives: Anti-cancer and cancer chemopreventive properties, mechanisms of action and structure- cytotoxic activity relationship","volume":"23","author":"Roohbakhsh","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jcis.2025.02.045_b0065","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejphar.2017.05.026","article-title":"The selective effect of glycyrrhizin and glycyrrhetinic acid on topoisomerase II\u03b1 and apoptosis in combination with etoposide on triple negative breast cancer MDA-MB-231 cells","volume":"809","author":"Cai","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jcis.2025.02.045_b0070","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.colsurfb.2018.11.082","article-title":"Glycyrrhetinic acid-conjugated polymeric prodrug micelles co-delivered with doxorubicin as combination therapy treatment for liver cancer","volume":"175","author":"Yang","year":"2019","journal-title":"Colloid Surface B"},{"issue":"21","key":"10.1016\/j.jcis.2025.02.045_b0075","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.7150\/thno.35972","article-title":"Co-delivery of glycyrrhizin and doxorubicin by alginate nanogel particles attenuates the activation of macrophage and enhances the therapeutic efficacy for hepatocellular carcinoma","volume":"9","author":"Wang","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.jcis.2025.02.045_b0080","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jconrel.2022.05.056","article-title":"Preparation and application of pH-responsive drug delivery systems","volume":"348","author":"Ding","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jcis.2025.02.045_b0085","article-title":"Emulsifying Lipiodol with pH-sensitive DOX@HmA nanoparticles for hepatocellular carcinoma TACE treatment eliminate metastasis","volume":"23","author":"Shi","year":"2023","journal-title":"Mater. Today Bio"},{"issue":"7","key":"10.1016\/j.jcis.2025.02.045_b0090","first-page":"1973","article-title":"The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment","volume":"6","author":"Yang","year":"2021","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jcis.2025.02.045_b0095","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jconrel.2022.08.031","article-title":"Oral administration of sodium bicarbonate can enhance the therapeutic outcome of Doxil\u00ae via neutralizing the acidic tumor microenvironment","volume":"350","author":"Ando","year":"2022","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jcis.2025.02.045_b0100","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1475-2867-13-89","article-title":"Acidic extracellular microenvironment and cancer","volume":"13","author":"Kato","year":"2013","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.jcis.2025.02.045_b0105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1054\/drup.2000.0119","article-title":"pH and drug resistance in tumors","volume":"3","author":"Raghunand","year":"2000","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.jcis.2025.02.045_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2019.01.004","article-title":"Sodium bicarbonate nanoparticles modulate the tumor pH and enhance the cellular uptake of doxorubicin","volume":"296","author":"Abumanhal-Masarweh","year":"2019","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.jcis.2025.02.045_b0115","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1248\/bpb.b21-00076","article-title":"Increasing tumor extracellular pH by an oral alkalinizing agent improves antitumor responses of anti-PD-1 antibody: implication of relationships between serum bicarbonate concentrations, urinary pH, and therapeutic outcomes","volume":"44","author":"Ando","year":"2021","journal-title":"Biol. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.jcis.2025.02.045_b0120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jcis.2025.02.045_b0125","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.actbio.2023.01.050","article-title":"A self-assembly nano-prodrug for triple-negative breast cancer combined treatment by ferroptosis therapy and chemotherapy","volume":"159","author":"Chen","year":"2023","journal-title":"Acta Biomater."},{"issue":"8","key":"10.1016\/j.jcis.2025.02.045_b0130","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202301271","article-title":"Stimulus-responsive nano-prodrug strategies for cancer therapy: a focus on camptothecin delivery","volume":"8","author":"Chu","year":"2024","journal-title":"Small Methods"},{"issue":"42","key":"10.1016\/j.jcis.2025.02.045_b0135","doi-asserted-by":"crossref","first-page":"35693","DOI":"10.1021\/acsami.8b09342","article-title":"Free adriamycin-loaded pH\/reduction dual-responsive hyaluronic acid-adriamycin prodrug micelles for efficient cancer therapy","volume":"10","author":"Yin","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"4","key":"10.1016\/j.jcis.2025.02.045_b0140","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.apsb.2023.01.017","article-title":"Recent progress of aptamer-drug conjugates in cancer therapy","volume":"13","author":"He","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"6","key":"10.1016\/j.jcis.2025.02.045_b0145","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1021\/acs.molpharmaceut.9b00072","article-title":"Small molecular theranostic assemblies functionalized by doxorubicin-hyaluronic acid-methotrexate prodrug for multiple tumor targeting and imaging-guided combined chemo-photothermal therapy","volume":"16","author":"Chen","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jcis.2025.02.045_b0150","doi-asserted-by":"crossref","first-page":"46057","DOI":"10.1038\/srep46057","article-title":"Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"issue":"44","key":"10.1016\/j.jcis.2025.02.045_b0155","doi-asserted-by":"crossref","first-page":"20851","DOI":"10.1039\/C8NR07201A","article-title":"Acidic pH-responsive polymer nanoparticles as a TLR7\/8 agonist delivery platform for cancer immunotherapy","volume":"10","author":"Kim","year":"2018","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.jcis.2025.02.045_b0160","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12951-021-00934-0","article-title":"Novel CD44-targeting and pH\/redox-dual-stimuli-responsive core-shell nanoparticles loading triptolide combats breast cancer growth and lung metastasis","volume":"19","author":"Shi","year":"2021","journal-title":"J Nanobiotechnology."},{"key":"10.1016\/j.jcis.2025.02.045_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.117998","article-title":"Calcium pectinate and hyaluronic acid modified lactoferrin nanoparticles loaded rhein with dual-targeting for ulcerative colitis treatment","volume":"263","author":"Luo","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jcis.2025.02.045_b0170","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jconrel.2018.07.028","article-title":"Tumor-targeting core-shell structured nanoparticles for drug procedural controlled release and cancer sonodynamic combined therapy","volume":"286","author":"Wang","year":"2018","journal-title":"J. Control. Release"}],"container-title":["Journal of Colloid and Interface Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021979725003960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021979725003960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T18:59:24Z","timestamp":1762196364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021979725003960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":34,"alternative-id":["S0021979725003960"],"URL":"https:\/\/doi.org\/10.1016\/j.jcis.2025.02.045","relation":{},"ISSN":["0021-9797"],"issn-type":[{"value":"0021-9797","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-delivery of doxorubicin and glycyrrhetinic acid via acid\/glutathione dual responsive nano-prodrug with sodium bicarbonate carry-on for advanced combinational cancer treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Colloid and Interface Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcis.2025.02.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}